ÇİFTÇİ, E. Et Al. 2017. DIAGNOSTIC IMPORTANCE OF 18F-FDG PET/CT PARAMETERS AND TOTAL LESION GLYCOLYSIS (TLG) IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT ADRENAL LESIONS. EANM’17- Annual Congress of the European Association of Nuclear Medicine (October 21 - 25, 2017 in Vienna/Austria). , 474.

ÇİFTÇİ, E., TURGUT, B., ÇAKMAKCILAR, A., & ERTÜRK, S. A., (2017). DIAGNOSTIC IMPORTANCE OF 18F-FDG PET/CT PARAMETERS AND TOTAL LESION GLYCOLYSIS (TLG) IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT ADRENAL LESIONS . EANM’17- Annual Congress of the European Association of Nuclear Medicine (October 21 - 25, 2017 in Vienna/Austria). (pp.474).

ÇİFTÇİ, ESRA Et Al. "DIAGNOSTIC IMPORTANCE OF 18F-FDG PET/CT PARAMETERS AND TOTAL LESION GLYCOLYSIS (TLG) IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT ADRENAL LESIONS," EANM’17- Annual Congress of the European Association of Nuclear Medicine (October 21 - 25, 2017 in Vienna/Austria)., 2017

ÇİFTÇİ, ESRA Et Al. "DIAGNOSTIC IMPORTANCE OF 18F-FDG PET/CT PARAMETERS AND TOTAL LESION GLYCOLYSIS (TLG) IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT ADRENAL LESIONS." EANM’17- Annual Congress of the European Association of Nuclear Medicine (October 21 - 25, 2017 in Vienna/Austria). , pp.474, 2017

ÇİFTÇİ, E. Et Al. (2017) . "DIAGNOSTIC IMPORTANCE OF 18F-FDG PET/CT PARAMETERS AND TOTAL LESION GLYCOLYSIS (TLG) IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT ADRENAL LESIONS." EANM’17- Annual Congress of the European Association of Nuclear Medicine (October 21 - 25, 2017 in Vienna/Austria). , p.474.

@conferencepaper{conferencepaper, author={ESRA ÇİFTÇİ Et Al. }, title={DIAGNOSTIC IMPORTANCE OF 18F-FDG PET/CT PARAMETERS AND TOTAL LESION GLYCOLYSIS (TLG) IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT ADRENAL LESIONS}, congress name={EANM’17- Annual Congress of the European Association of Nuclear Medicine (October 21 - 25, 2017 in Vienna/Austria).}, city={}, country={}, year={2017}, pages={474} }